Drug Type Biological products |
Synonyms VXM 04, VXM04 |
Target |
Action modulators |
Mechanism MSLN modulators(Mesothelin modulators) |
Active Indication- |
Inactive Indication |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatic Cancer | Preclinical | Switzerland | 01 Sep 2022 |





